• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Insights & Articles
    • The Clinical Landscape: Strategic Insights into Retinal Care
      • The Modern Clinical Retina Landscape: A Strategic Overview
      • Surgical Approaches to Retinal Detachment: A Comparative Analysis
      • Gene Therapy in Retina: A Commercial and Clinical Appraisal
      • Evolving Treatment Paradigms for Diabetic Macular Edema
      • Analysis of the Anti-VEGF Market: From Revolution to Refinement
      • A Patient’s Guide to Understanding Age-Related Macular Degeneration (AMD)
    • The Business of Retina: Mastering Operations and Financial Health
      • Anatomy of a Retina Practice: A Strategic Guide to Financial Health and Operations
      • The Impact of Private Equity: Reshaping the Business of Retina
      • The Complete 2025 Guide to Ophthalmic J-Codes & Reimbursement
      • The Buy-and-Bill Model: A High-Risk, High-Reward Strategy
      • Staffing for Success: Key Roles in a High-Volume Retina Practice
      • Key Technology Investments for an Efficient Retina Clinic
      • Decoding CMS Reimbursement: A Guide to J-Codes and Revenue Cycle Management
    • The Innovation Pipeline: Shaping the Future of Retinal Care
      • Beyond the Needle: The Future of Drug Delivery in Retina
      • Heads-Up vs. Traditional: A Comparison of Surgical Visualization Platforms
      • How AI is Changing the Game in Retinal Disease Screening
      • The Rise of At-Home Monitoring for AMD
    • The Professional Ecosystem: Building a Career in Retina
      • A Day in the Life of a Retina Specialist: A Day of Preserving Sight
      • Industry vs. Academia: Choosing Your Career Path in Retina
      • The Role of Key Opinion Leaders (KOLs) in Retina
      • Maximizing Your ASRS Experience: A Fellow’s Guide
      • Navigating the Retina World: A Guide to Key Societies, Conferences, and Career Paths
  • Services
    • Search Engine Optimization (SEO) & Reputation Management
    • Content Marketing & Optometrist Network Development
    • Specialized Recruitment & Staffing Support
    • Professional Branding & Key Opinion Leader (KOL) Development
    • On-Demand Patient Education & Marketing Materials
    • Market Intelligence & M&A Consulting
  • Contact Us
    • Events
    • Subscribe
    • Submissions
Retina Consultant

Retina Consultant

Visionary News & Insightful Strategy

Retina Roundup Advertisement

In-office dry eye treatments: Tried, true and new

March 19, 2026 by Healio Ophthalmology

Click here to view the original post by Healio Ophthalmology.

In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication. 

By clicking the link above, you will be leaving our site to view an article from its original source.


Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.

Please enable JavaScript in your browser to complete this form.
Loading


With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease treatments, we are talking about treating meibomian gland dysfunction and evaporative dry eye.
For decades, meibomian gland dysfunction treatment began and ended with warm compresses and baby shampoo scrubs. Medical advice consisted of insisting that your patient use Johnson’s baby shampoo. Perhaps the first real breakthrough was the discovery of the presence of biofilm on the lid surface, typically associated with staph species. As is so often the case, research led by Hank

Filed Under: News

Primary Sidebar

More to See

Vitamin D Levels May Correlate With Proliferative Vitreoretinopathy Risk After RRD

March 19, 2026 By AAO News Feed

In-office dry eye treatments: Tried, true and new

March 19, 2026 By Healio Ophthalmology

Clinician involvement key to safe, trusted AI use in health care

March 19, 2026 By Healio Ophthalmology

Fundus Autofluorescence as a Sensitive Biomarker of Disease Progression in Bietti Crystalline Dystrophy

March 18, 2026 By Ophthalmology Science

Weekly Journal Update — March 18, 2026

March 18, 2026 By AAO News Feed

Corneal microlens easy to explant for cataract surgery

March 18, 2026 By Healio Ophthalmology

For third time, FDA does not approve reproxalap for dry eye

March 18, 2026 By Healio Ophthalmology

A Case Series Reveals Features and Outcomes of Ballpoint Pen–Related Penetrating Injuries

March 18, 2026 By AAO News Feed

Patients with GA require careful screening, opportunity for treatment

March 18, 2026 By Healio Ophthalmology

VIDEO: ‘Dramatic breakthroughs’ expected in neurotrophic keratitis

March 18, 2026 By Healio Ophthalmology

Footer

A RETINA-SPECIFIC ORGANIZATION

It’s clearly an advantage to work with a consulting group that’s focused on your industry. The team at Retina Consultant has over 50 years of retina-specific experience in healthcare business, practice management, marketing & operations.

We’ve got our eyes on working with the best retina groups and vendors in the industry.

See the best;  get in touch.

Recent News Posts

  • Ndemex aims to be ‘part of daily ocular hygiene routine’
  • Vitamin D Levels May Correlate With Proliferative Vitreoretinopathy Risk After RRD
  • In-office dry eye treatments: Tried, true and new
  • Clinician involvement key to safe, trusted AI use in health care
  • Fundus Autofluorescence as a Sensitive Biomarker of Disease Progression in Bietti Crystalline Dystrophy

Search

Retina Consultant
Copyright © 2026